companyHealth Information Technology & Clinical Decision SupportNetherlands

Wolters Kluwer Health (UpToDate/Medi-Span)

Global provider of clinical decision support and drug data solutions, including UpToDate and Medi-Span, serving clinicians in 190+ countries.

Wolters Kluwer – About Us / Organization

Wolters Kluwer Health is the healthcare division of Wolters Kluwer, a global information solutions company headquartered in Alphen aan den Rijn, the Netherlands, with U.S. Health operations based in Waltham, Massachusetts. The parent company reported 2025 annual revenues of €6.1 billion, employs approximately 21,100 people, and serves customers in over 180 countries across sectors including health, legal, tax, and financial compliance.

UpToDate is the division's flagship clinical decision support resource, authored by physicians and grounded in evidence-based medicine. More than 1.9 million clinicians across 190+ countries use it at the point of care, and over 80 research studies associate its widespread use with improved patient outcomes and hospital performance. A 2021 subscriber survey found 93% of users trust it as a clinical resource and 95% believe it helps them stay current.

Medi-Span is Wolters Kluwer Health's suite of embedded drug data solutions, widely integrated by EMR vendors and used across hospitals, ambulatory practices, specialty clinics, and pharmacies worldwide to support medication-related decisions at the point of care.

Wolters Kluwer Health is actively expanding into AI-driven clinical tools, having announced UpToDate Expert AI—a generative AI-powered clinical decision support solution—and Medi-Span Expert AI, designed to deliver medication intelligence for digital health developers via an MCP server. These innovations position the company at the intersection of established clinical data authority and next-generation AI-assisted healthcare delivery.

Ideas that could help Wolters Kluwer Health (UpToDate/Medi-Span)

Immunosuppression Neurotoxicity Risk Scorer for Organic Acidurias Post-Transplant
A clinical decision-support tool that quantifies and monitors immunosuppression-related neurotoxicity risk in pediatric liver transplant patients with organic acidurias, enabling individualized drug selection and dosing to prevent drug-induced neurological damage.
Why it helps: Operates major clinical decision support and drug-interaction databases embedded in hospital EHRs; this specialized neurotoxicity ruleset would be a high-value add-on module for transplant and metabolic disease clients.